Terray Therapeutics, a Los Angeles biotech firm, raised $120M in Series B funding.

Led by Bedford Ridge Capital and NVIDIA’s NVentures, the round included Maverick Capital, Madrona Ventures, and others.

The funds will propel clinical trials of internal programs and enhance Terray's AI platform, tNova, for drug discovery.

Specializing in small molecule therapeutics, Terray partners with Bristol Myers Squibb and Calico on challenging targets.